-
1Academic Journal
المؤلفون: Yu. N. Krovko, A. V. Shmigelskiy, A. D. Аkhmedov, A. A. Shulgina, V. A. Lukshin, D. Yu. Usachev, Ю. Н. Кровко, А. В. Шмигельский, А. Д. Ахмедов, А. А. Шульгина, В. А. Лукшин, Д. Ю. Усачёв
المصدر: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 18, № 1 (2021); 84-92 ; Вестник анестезиологии и реаниматологии; Том 18, № 1 (2021); 84-92 ; 2541-8653 ; 2078-5658
مصطلحات موضوعية: тромбоз глубоких вен, enoxaparin, low molecular weight heparins, hepatotoxicity, deep vein thrombosis, эноксапарин, низкомолекулярные гепарины, гепатотоксичность
وصف الملف: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/501/471; Государственный реестр лекарственных средств. Инструкция по медицинскому применению препарата Гепабене. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=1629b696-7bc5-422b-a3ef-ee4eb400fde3&t= (дата обращения: 19.01.2020).; Государственный реестр лекарственных средств. Инструкция по медицинскому применению препарата Урсосан. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=75ee02eb-a348-49eb-bd05-d74f693f081a&t= (дата обращения: 19.01.2020).; Государственный реестр лекарственных средств. Инструкция по применению лекарственного препарата для медицинского применения Креон 25000. [Электронный ресурс]. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ac439cc-d78c-4d8f-9ffe-a085984979fb&t= (дата обращения: 19.01.2020).; Ивашкин В. Т., Барановский А. Ю., Райхельсон К. Л. и др. Лекарственные поражения печени (клинические рекомендации для врачей) // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. ‒ 2019. ‒ Т. 29, № 1. ‒ С. 101‒131. https://doi.org/10.22416/1382-4376-2019-29-1-101-131.; Пиманов С. И., Макаренко Е. В. Идиосинкразические лекарственные поражения печени: диагностика и лечение // Медицинский совет. ‒ 2017. ‒ № 5. ‒ С. 100‒107. https://doi.org/10.21518/2079-701X-2017-5-100-107.; Arora N., Goldhaber S. Z. Anticoagulants and transaminase elevation // Circulation. ‒ 2006. ‒ Vol. 113, № 15. ‒ P. 698‒702. https://doi.org/10.1161/CIRCULATIONAHA.105.603100.; Baker E. L., Loewenthal T., Salerno E. et al. Probable enoxaparin-induced hepatotoxicity // Am. J. Heal. Pharm. ‒ 2009. ‒ Vol. 66, № 7. ‒ P. 638‒641. https://doi.org/10.2146/ajhp080311.; Bosco M., Kish T. Hepatotoxicity with elevated bilirubin secondary to prophylactic doses of unfractionated heparin: a case report and review of heparin-induced hepatotoxicity // J. Pharm. Technol. ‒ 2019. ‒ Vol. 35, № 1. ‒ P. 36‒40. https://doi.org/10.1177/8755122518803363.; Cano-Paniagua A., Amariles P., Angulo N. et al. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: updated RUCAM being used for prospective causality assessment // Ann. Hepatol. ‒ 2019. ‒ Vol. 18, № 3. ‒ P. 501‒507. https://doi.org/10.1016/j.aohep.2018.11.008.; Carlson M. K., Gleason P. P., Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity // Pharmacotherapy. ‒ 2001. ‒ Vol. 21, № 1. ‒ P. 108‒113. https://doi.org/10.1592/phco.21.1.108.34436.; Danan G., Teschke R. RUCAM in drug and herb induced liver injury: the update // Int. J. Mol. Sci. ‒ 2015. ‒ Vol. 17, № 1. ‒ P. 1‒33. https://doi.org/10.3390/ijms17010014.; Di Saia P. J., Creasman W. T., Mannel R. S. et al. Clinical Gynecologic Oncology 9th edition. ‒ Philadelphia, PA. Elsevier, Inc. ‒ 2018. ‒ P. 1‒631.; Faraoni D., Comes R. F., Geerts W. et al. European guidelines on perioperative venous thromboembolism prophylaxis // Eur. J. Anaesthesiol. ‒ 2018. ‒ Vol. 35, № 2. ‒ P. 90‒95. https://doi.org/10.1097/EJA.0000000000000710.; Guidance for industry drug-induced liver injury: premarketing clinical evaluation. ‒ 2009. ‒ P. 1‒25. [Электронный ресурс]. URL: https://www.health.qld.gov.au/__data/assets/pdf_file/0023/147533/qh-gdl-951.pdf (дата обращения: 19.01.2020).; Guideline for anticoagulation and prophylaxis using low molecular weight heparin (LMWH) in adult inpatients. ‒ 2016. ‒ P. 1‒15. [Электронный ресурс]. URL: https://www.health.qld.gov.au/__data/assets/pdf_file/0023/147533/qh-gdl-951.pdf (дата обращения 19.01.2020).; Hahn K. J., Morales S. J., Lewis J. H. Enoxaparin-induced liver injury: case report and review of the literature and FDA adverse event reporting system (FAERS) // Drug. Saf. ‒ 2015. ‒ Vol. 2, № 1. ‒ P. 1‒11. https://doi.org/10.1007/s40800-015-0018-0.; Harrill A. H., Roach J., Fier I. et al. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers // Clin. Pharmacol. Ther. ‒ 2012. ‒ Vol. 92, № 2. ‒ P. 214‒220. https://doi.org/10.1038/clpt.2012.40.; Hayashi P. H., Rockey D. C., Fontana R. J. et al. Death and liver transplantation within 2 years of onset of drug-induced liver injury // Hepatology. ‒ 2017. ‒ Vol. 66, № 4. ‒ P. 1275‒1285. https://doi.org/10.1002/hep.29283.; Hoofnagle J. H., Björnsson E. S. Drug-induced liver injury-types and phenotypes // N. Engl. J. Med. ‒ 2019. ‒ Vol. 381, № 3. ‒ P. 264‒273. https://doi.org/10.1056/NEJMra1816149.; Hui C., Yuen M., Ng I. O. et al. Low molecular weight heparin-induced liver toxicity // J. Clin. Pharmacol. ‒ 2001. ‒ Vol. 41. ‒ P. 691‒694. https://doi.org/10.1177/00912700122010465.; Kleiner D. E., Chalasani N. P., Lee W. M. et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations // Hepatology. ‒ 2014. ‒ Vol. 59, № 2. ‒ P. 661‒670. https://doi.org/10.1002/hep.26709.; Leo M., Ponziani F. R., Nesci A. et al. Low molecular weight heparin as cause of liver injury: case report and literature review // Eur. Rev. Med. Pharmacol. Sci. ‒ 2019. ‒ Vol. 23, № 17. ‒ P. 7649‒7654. https://doi.org/10.26355/eurrev_201909_18888.; Nguyen A., Dasgupta A., Wahed A. Management of hemostasis and coagulopathies for surgical and critically ill patients: an evidence-based approach 1st edition. ‒ Elsevier, Inc. ‒ 2016. ‒ P. 1-174.; Nissenson A. R., Fine R. N. Handbook of dialysis therapy. Philadelphia, PA. Elsevier, Inc. ‒ 2017. ‒ P. 1‒1171.; Robles-Diaz M., Isabel Lucena M., Kaplowitz N. et al. Use of hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury // Gastroenterology. ‒ 2014. ‒ Vol. 147, № 1. ‒ P. 109‒118.e5. https://doi.org/10.1053/j.gastro.2014.03.050.; Sonnenblick M., Oren A., Jacobsonn W. Hyper-transaminasemia with heparin therapy // Br. Med. J. ‒ 1975. ‒ Vol. 3. ‒ P. 77. https://doi.org/10.1136/bmj.3.5975.77.; Thakkar S., Li T., Liu Z. et al. Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity // Drug. Discov. Today. ‒ 2019. ‒ Vol. 25, № 1. ‒ Р. 201‒208. https://doi.org/10.1016/j.drudis.2019.09.022.; Watkins P.B. Idiosyncratic drug-induced liver injury in patients: detection, severity assessment, and regulatory implications 1st edition // Advanc. Pharmacol. ‒ 2019. ‒ Vol. 85. ‒ P. 165‒193. https://doi.org/10.1016/bs.apha.2019.02.004.; https://www.vair-journal.com/jour/article/view/501
-
2Academic Journal
المؤلفون: A. A. Kurbasov, A. V. Shmigelskiy, A. D. Аkhmedov, V. A. Lukshin, D. Yu. Usachev, А. А. Курбасов, А. В. Шмигельский, А. Д. Ахмедов, В. А. Лукшин, Д. Ю. Усачёв
المصدر: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 17, № 5 (2020); 95-105 ; Вестник анестезиологии и реаниматологии; Том 17, № 5 (2020); 95-105 ; 2541-8653 ; 2078-5658
مصطلحات موضوعية: интраоперационная гипертензия, hormone-active carotid glomus paragangliomas, anesthetic support, intraoperative hypertension, гормонально-активные параганглиомы каротидного гломуса, анестезиологическое обеспечение
وصف الملف: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/471/451; Коваль И. В. Параганглиомы основания черепа: Клиника, диагностика и тактика лечения: Дис. … канд. мед. наук. ‒ М., 1989.; Куликов А. С., Лубнин А. Ю. Дексмедетомидин: новые возможности в анестезиологии // Анестезиология и реаниматология. ‒ 2013. ‒ Т. 58, № 1. ‒ С. 37‒41.; Лубнин А. Ю., Цейтлин А. М., Коваль И. В. и др. Анестезиологическое обеспечение при удалении опухоли югулярного гломуса. Первый опыт применения урапидила // Анестезиология и реаниматология. ‒ 1996. Т. 41, № 2. ‒ С. 50‒53.; Усачев Д. Ю., Арустамян С. Р., Лубнин А. Ю. и др. Комбинированное хирургическое лечение каротидной параганглиомы // Журнал Вопросы нейрохирургии им. ак. Н. Н. Бурденко. ‒ 2004. ‒ T. 68, № 3. ‒ С. 27‒30.; Ahmad T., Patil S., Pasarad A. K. et al. Paraganglioma masquerading as acute myocardial infarction and cardiogenic shock // Indian Heart J. ‒ 2016. ‒ Vol. 68, Suppl. 2. ‒ P. 258‒263.; Ali E. M., Selim O. A., Ozgul U. et al. Dexmedetomidine, Remifentanil, and Sevoflurane in the perioperative management of a patient during a laparoscopic pheochromocytoma resection // J. Cardiothor. Vasc. Anesthesia. 2015. ‒ Vol. 29, № 6. ‒ Р. 79‒80.; Amato B., Serra R., Fappiano F. et al. Surgical complications of carotid body tumors surgery: a review // Int. Angiol. ‒ 2015. ‒ Vol. 34, № 6, Suppl. 1. ‒ P. 15‒22.; Baysal A., Sasmazel A., Bugra O. et al. Necessity of adequate monitoring during carotid body tumors // Anatol. J. Cardiol. ‒ 2010. ‒ Vol. 10, № 4. ‒ P. 380‒381.; Berdal P., Braaten M., Cappelen C. Jr. et al. Noradrenaline-adrenaline producing nonchromaffin paraganglioma // Acta. Med. Scand. ‒ 1962. ‒ Vol. 172, № 2. P. 249‒257.; Bryskin R., Weldon B. C. Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas // J. Clin. Anesthesia. ‒ 2010. ‒ Vol. 22, № 2. P. 126‒129.; Chen Y., Li Y., Liu J. et al. The clinical characteristics and outcomes of carotid body tumors in Chinese patients: A STROBE-compliant observational study // Medicine (Baltimore). ‒ 2020. ‒ Vol. 99, № 3. ‒ P. e18824.; Clarke A. D., Matheson H., Boddie H. G. Removal of catecholamine-secreting chemodectoma. The use of neuroleptanaesthesia, adrenergic blockade and sodium nitroprusside // Anaesthesia. ‒ 1976. ‒ Vol. 31, № 9. ‒ P. 1225‒1230.; Cobb A. N., Barkat A., Daungjaiboon W. et al. Carotid body tumor resection: just as safe without preoperative embolization // Ann. Vasc. Surg. ‒ 2018. Vol. 46. ‒ P. 54‒59.; Connor D., Boumphrey S. Perioperative care of phaeochromocytoma // BJA Education. ‒ 2016. ‒ Vol. 16, № 5. ‒ P. 153‒158.; Dixon J. L., Atkins M. D., Bohannon W. T. et al. Surgical management of carotid body tumors: a 15-year single institution experience employing an interdisciplinary approach // Proc. (Bayl. Univ. Med. Cent.). ‒ 2016. ‒ Vol. 29, № 1. ‒ P. 16‒20.; Duke W. M., Phillips M. W., Donald J. M. Jr. et al. A Norepinephrine-secreting glomic tissue tumor (chemodectoma) // JAMA. ‒ 1965. ‒ Vol. 193, № 1. ‒ P. 20‒22.; Elshafie O., Al Badaai Y., Alwahaibi K. et al. Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide // Endocrinology, Diabetes & Metabolism Case Reports. ‒ 2014. ‒ № 1. ‒ P. 140051.; Farage M., Costa M. A., Godoy-Matos A. F. A rare case of Cushing syndrome by cyclic ectopic-ACTH // Arquivos Brasileiros de Endocrinologia & Metabologia. ‒ 2012. ‒ Vol. 56, № 5. ‒ P. 324‒330.; Farr H. W. Carotid body tumors: a 40-year study // CA Cancer J. Clin. ‒ 1980. Vol. 30, № 5. ‒ P. 260‒265; Giavarini A., Chedid A., Bobrie G. et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma // Heart. 2013. ‒ Vol. 99, № 19. ‒ P. 1438‒1444.; Glenner G. G., Crout J. R., Roberts W. C. A functional carotid-body-like tumor. Secreting levarterenol // Arch. Pathol. ‒ 1962. ‒ Vol. 73. ‒ P. 230‒240.; Granell M., Tommasi M., Ubeda J. et al. Anesthesia for carotid paraganglioma exeresis. Report of 3 cases // Rev. Esp. Anestesiol. Reanim. ‒ 2001. ‒ Vol. 48, № 8. ‒ P. 387‒392.; Guardo L. A., Gala C. C., Calvo A. R. et al. Known difficult airway in a patient with pheochromocytoma: a case report // J. Clin. Anesthesia. ‒ 2016. ‒ Vol. 35. ‒ P. 411‒414.; Hallett J. W., Nora J. D., Hollier L. H. et al. Trends in neurovascular complications of surgical management for carotid body and cervical paraganglionmas: A fifty-year experience with 153 tumors // J. Vasc. Surgery. ‒ 1988. ‒ Vol. 7, № 2. ‒ P. 284‒291.; Hirano S., Shoji K., Kojima H. et al. Dopamine-secreting carotid body tumor // Am. J. Otolaryngol. ‒ 1998. ‒ Vol. 19, № 6. ‒ P. 412‒416.; Hoang V. T., Trinh C. T., Lai T. A. K. et al. Carotid body tumor: a case report and literature review // J. Radiol. Case Reports. ‒ 2019. ‒ Vol. 13, № 8. ‒ P. 19‒30.; Hu K., Persky M. S. Treatment of head and neck paragangliomas // Cancer Control. ‒ 2016. ‒ Vol. 23, № 3. ‒ P. 228‒241.; Hua Q., Xu Z., Jiang Y. Diagnosis and surgical treatment of carotid body tumor: A retrospective analysis of 58 patients // Oncology Letters. ‒ 2017. ‒ Vol. 14, № 3. ‒ P. 3628‒3632.; Jagtap S. R., Bakhshi R. G., Khatavkar S. S. et al. Carotid body tumour excision: Anaesthetic challenges and review of literature // Indian J. Anaesth. ‒ 2013. Vol. 57, № 1. ‒ P. 76‒78.; Jeffery J., Devendra D., Farrugia J. et al. Increased urinary dopamine excretion in association with bilateral carotid body tumours ‒ clinical, biochemical and genetic findings // Ann. Clin. Biochem. ‒ 2006. ‒ Vol. 43, № 2. ‒ P. 156‒160.; Joseph T., Shetty N., Chaudhuri S. et al. Child with bilateral pheochromocytoma and a surgically solitary kidney: Anesthetic challenges // Saudi J. Anaesthesia. 2013. ‒ Vol. 7, № 2. ‒ P. 197‒199.; LaMuraglia G. M., Fabian R. L., Brewster D. C. et al. The current surgical management of carotid body paragangliomas // J. Vasc. Surgery. ‒ 1992. ‒ Vol. 15, № 6. ‒ P. 1038‒1045.; Lenders J. W. M., Duh Q. Y., Eisenhofer G. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline // J. Clin. Endocrinology & Metabolism. ‒ 2014. ‒ Vol. 99, № 6. ‒ P. 1915‒1942.; Lopez C. T., Hernandez M. V., Briz S. E. et al. Anesthesia in head and neck paragangliomas // Acta. Otorrinolaringol. Esp. ‒ 2009. ‒ Vol. 60, Suppl. 1. ‒ P. 76‒79.; Malliwal A., Mohite S., Doshi N. et al. Anaesthetic challenges in carotid body tumour resection: a case report and review of literature // Intern. J. Res. Med. Sci. ‒ 2015. ‒ Vol. 3, № 12. ‒ P. 3897‒3900.; Matticari S., Credi G., Pratesi C. et al. Diagnosis and surgical treatment of the carotid body tumors // J. Cardiovasc. Surg. (Torino). ‒ 1995. ‒ Vol. 36, № 3. ‒ P. 233‒239.; Naik S. M., Shenoy A. M., Nanjundappa H. R. et al. Paragangliomas of the carotid body: current management protocols and review of literature // Indian J. Surg. Oncol. ‒ 2013. ‒ Vol. 4, № 3. ‒ P. 305‒312.; Ng D. W., Yam C. I., Wong L. T. et al. An anaesthesia perspective on carotid body tumour (CBT) excision: A twenty-year case series at the Singapore General Hospital // J. Perioper. Pract. ‒ 2017. ‒ Vol. 27, № 10. ‒ P. 228‒233.; Offergeld C., Brase C., Yaremchuk S. et al. Head and neck paragangliomas: clinical and molecular genetic classification // Clinics (Sao Paulo). ‒ 2012. Vol. 67, Suppl. 1. ‒ P. 19‒28.; Puggioni A., Delis K. T., Fields C. E. et al. Large symptomatic carotid body tumor resection aided by preoperative embolization and mandibular subluxation // Perspect. Vasc. Surg. Endovasc. Ther. ‒ 2005. ‒ Vol. 17, № 1. ‒ P. 21‒28.; Ramachandran R., Rewari V. Current perioperative management of pheochromocytomas // Indian J. Urol. ‒ 2017. ‒ Vol. 33, № 1. ‒ P. 19‒25.; Schumann R., Hudcova J. Dexmedetomidine infusion during surgery in patients with a pheochromocytoma // Acta Anaesthesiologica Scandinavica. 2010. ‒ Vol. 54, № 3. ‒ P. 393‒394.; Singh S., Singh A. Dexmedetomidine induced catecholamine suppression in pheochromocytoma // J. Nat. Sci. Biol. Med. ‒ 2014. ‒ Vol. 5, № 1. ‒ P. 182‒183.; Snitzer J. L., Sheeler L. R., Bravo E. L. et al. A carotid body and glomus jugulare paraganglioma secreting norepinephrine // Endocr. Pract. ‒ 1995. ‒ Vol. 1, № 2. ‒ P. 82‒85.; Texakalidis P., Charisis N., Giannopoulos S. et al. Role of preoperative embolization in carotid body tumor surgery: a systematic review and meta-analysis // World Neurosurg. ‒ 2019. ‒ Vol. 129. ‒ P. 503‒513.; Whitwam J. G. APUD cells and the apudomas. A concept relevant to anaesthesia and endocrinology // Anaesthesia. ‒ 1977. ‒ Vol. 32, № 9. ‒ P. 879‒888.; Williams M. D. Paragangliomas of the Head and neck: an overview from diagnosis to genetics // Head Neck Pathol. ‒ 2017. ‒ Vol. 11, № 3. ‒ P. 278‒287.; Wright D. J., Pandya A., Noel F. Anaesthesia for carotid body tumour resection. A case report and review of the literature // Anaesthesia. ‒ 1979. ‒ Vol. 34, № 8. ‒ P. 806‒808.; Zeng G., Feng H., Zhao J. et al. Clinical characteristics and strategy for treatment of functional carotid body tumours // Intern. J. Oral Maxillofacial Surgery. 2013. ‒ Vol. 42, № 4. ‒ P. 436‒439.; Zeng G., Zhao J., Ma Y., et al. A Comparison between the treatments of functional and nonfunctional carotid body tumors // Ann. Vasc. Surgery. 2012. ‒ Vol. 26, № 4. ‒ P. 506‒510.; Zhang W. D., Zhang D. S., Liu J. J. et al. Clinical analysis of 19 carotid body tumors // Shanghai J. Stomatol. ‒ 2007. ‒ Vol. 16, № 6. ‒ P. 660‒664.; https://www.vair-journal.com/jour/article/view/471